期刊文献+

国内外破伤风相关疫苗的质量参数比较 被引量:1

Comparison of Quality Parameters of Domestic and Imported Tetanus-based Combined Vaccines
原文传递
导出
摘要 目的了解基础免疫阶段在我国市场上主要使用的国内外破伤风相关疫苗的关键质量参数及其水平。方法以国内外各厂家分别生产的10批次产品为依据,对其质量数据进行统计、分析和比较。结果国产产品和进口产品各有其优势所在,同时也均有需进一步提升的空间。结论期望更多国内外疫苗厂家能针对自身产品特点,进一步提高产品质量,在未来制造出更安全、有效且使用便捷的新型疫苗。 OBJECTIVE To investigate the situation of the key quality parameters of the main domestic and imported tetanus- based combined vaccines used in the basic immunization phase in our country. METHODS The quality parameters of 50 batches of vaccine products which were manufactured respectively by domestic and foreign manufacturers were analyzed and compared. RESULTS AND CONCLUSION Domestic and imported tetanus-based combined vaccine products have different advantages and the quality and these products may be improved further in some respects. It is suggested that more domestic and foreign vaccine manufacturers improve the product quality based on the characteristics of their own products to provide safer and more effective vaccines that can also more convenient for use in the future.
出处 《中国药学杂志》 CAS CSCD 北大核心 2015年第8期714-717,共4页 Chinese Pharmaceutical Journal
基金 中国食品药品检定研究院中青年发展研究基金资助(2013NB3)
关键词 破伤风相关疫苗 质量参数 比较 tetanus-based combination vaccines quality parameter comparison
  • 相关文献

参考文献11

  • 1Ch.P(2010)Vol Ⅲ(中国药典2010年版.三部)[S].2010:67-68,notice Ⅺ.
  • 2WANG D S, ZHAO H, DONG S L. The adverse reaction review of tetanus toxoid[ J]. 微生物学免疫学进展,1995,23(3):179-183.
  • 3SCHIJNS V E, LAVELLE E C. Trends in vaccine adjuvants[ J]. Expert Rev Vaccines,2011,10(4) :539-550.
  • 4FREDERIKSENMS, TOFTE H. Immunisation with aluminium- containing vaccine of a child with itehing nodule following previ- ous vaccination [ J ]. Vaccine, 2004,23 ( 1 ) : 1-2.
  • 5BORDET A L, MICHENET P, COHEN C, et al. Post-vaccina- tion granuloma due to aluminium hydroxide [ J ]. Ann Pathol, 2001,21 (2) :149-152.
  • 6BAYLOR N W, EGAN W, RICHMAN P. Aluminum salts in vac- cines--US perspective[J]. Vaccine, 2002,20(suppl 3) :18-23.
  • 7VAN'T VEEN A J. Vaccines without thiomersal:Why so necessa- ry,Why so long coming[ J]. Drugs, 2001,61 (5) :565-572.
  • 8ABERER W, REITER E, ZIEGLER V, et al. The importance of including thimerosal, an increasingly frequent allergen in Eu- rope, in standard screening series for allergic contact dermatitis [J]. Am J Contact Dermat ,1991, 2 ( 2 ) :110-112.
  • 9WHO. Guidelines on regulatory expectations related to the elimi- nation, reduction or replacement of thiomersal in vaccines [ R ]. WHO TRS, NO. 926, 2004.
  • 10Committee for Proprietary Medicinal Products. Points to consider on the reduction, eliminationor substitution of thiomersal in vac- cines[ R]. CPMP/BWP/2517/00,2001.

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部